EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN DAY ONE BIOPHARMACEUTICALS, INC. AND IPSEN PHARMA SAS JULY 23, 2024Exclusive License Agreement • October 30th, 2024 • Day One Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
This EXCLUSIVE LICENSE AGREEMENT (“Agreement”) is entered into as of July 23, 2024 (the “Effective Date”), by and between Day One Biopharmaceuticals, Inc., a Delaware corporation located at 2000 Sierra Point Parkway, Suite 501, Brisbane, CA 94005 (“Day One”) and Ipsen Pharma SAS, a French corporation located at 65 Quai Georges Gorse, 92100 Boulogne- Billancourt, France (“Licensee”). Day One and Licensee may be referred to in this Agreement individually as a “Party” or collectively as the “Parties.”
